GH

GeneDx Holdings Corp.

WGS·NASDAQ

$53.02

+2.0%
HealthcareMedical - Healthcare Information Services

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

At a Glance

Live Snapshot
Market Cap$1.57B
EPS-0.7300
P/E Ratio-72.63
Earnings Date08/04/2026

No Dividend Yield Data

WGS has not reported any dividend yield values in the available annual periods.

No Dividend Payout Ratio Data

WGS has not reported any dividend payout ratio values in the available annual periods.

No Net Dividends Paid Data

WGS has not reported any net dividends paid values in the available annual periods.

GH

GeneDx Holdings Corp. Dividend History

WGS · NASDAQ
10Y CAGR +0%
Latest $0
Annual $0
Stable dividend payments
Last Period: +0%

WGS Dividend Payment History

WGS · NASDAQ
DeclarationEx-DatePayment DateDividendAdjustedFrequencyGrowth
No dividend payment history available
w

GeneDx Holdings Corp. Payout Ratio Analysis

WGS · NASDAQ
Dividends Paid
0.00
2025
Net Income
-21.02M
2025
Payout Ratio
0.00%
2025

Dividend Sustainability Analysis

Payout Ratio
0.00%

Conservative payout with excellent safety margin. Company retains significant earnings for growth, acquisitions, or building cash reserves. Dividend is highly sustainable.

FCF Payout Ratio
0.0%

Excellent FCF coverage. Dividend is well-supported by actual cash generation with ample room for increases and business reinvestment.

Sustainability
Fair

Dividend sustainability questionable. Monitor closely for signs of stress. Consider whether yield justifies the risk.